• Macy's (M) is awaiting a ruling today in the Martha Stewart case. The company already hit a new 52-week high yesterday when a judge refused to throw out the chain's case against the domestic diva. On the table now, whether JC Penney (JCP) should be blocked temporarily from selling some of Martha's wares. The products were expected to be shipped to stores this spring. Macy's shares are up more than 3% just this week, as the trial unfolds. By the way, as for Penney, the company is now trying to raise $1-billion in cash so it can rebuild rather than go bankrupt. One scenario has it selling a stake to private equity.

    Next is Harris Corp (HRS), which plummeted after the closing bell yesterday, saying it's hurting from the sequester. Harris makes wireless network transmission equipment. The company says it's being forced to lay off workers and cut expenses because key orders have been pushed back by the spending cuts. Harris has really been left behind in this year's market boom. At last

    Read More »from Stocks to Watch: Macy’s Awaits Martha Ruling, Eli Lilly Layoffs, Chipotle Causing Heartburn
  • Two big bank "tellers." J-P Morgan (JPM) and Wells Fargo (WFC) are both out with quarterly earnings this morning. They beat on earnings per share, but what's the bigger picture? Yahoo! Finance "Hot Stock Minute" host Lauren Lyster discusses the reports with Yahoo! Finance Senior Columnist Mike Santoli. The pair also review the March Retail Sales number which missed estimates. They also look at where the markets are likely to go from their current record high.

    Read More »from Morning Analysis: JPM and WFC Beat on EPS, March Retail Sales Miss
  • "No matter what the circumstances, always offer hope. If you ever rob someone of hope, then you have sealed the outcome one way or the other," said Dr. Anthony Coles, the chairman and CEO of Onyx Pharmaceuticals. Onyx is a biopharmaceutical company that develops therapies for treating cancer—it has three drugs that are approved to treat five types of cancer. The company’s 2012 revenue reached $362.2 million, and its stock has more than doubled in the past year.

    “Running a cancer company is all about providing hope,” Dr. Coles told “Off The Cuff.” It was a lesson that he said was brought home to him when his own son was diagnosed with non-Hodgkin’s lymphoma, at the age of 12. “I actually noticed that his sternum, or the chest bone, was protruding and knew immediately that something was wrong. He was rushed to the hospital and we were hoping against hope that what I knew was true, wasn't going to be. But alas, it was,” he said.

    Read More »from Biopharma CEO: You Really Get It When You’re Treating Your Own Son
  • Stocks seem unstoppable. Both the Dow and the S&P closed at new record highs today. The Nasdaq moved slightly higher. Markets were boosted by a better-than-expected report from the Labor Department on weekly jobless claims. There were just 346,00 new claims filed last week. That was a drop of 42,000 from the week before. A separate report from the Labor Department eased concerns about inflation. Import prices dipped 0.5% last month after rising 0.6% in February. For March, a rise in food prices was offset by a decline in fuel prices.

    Burger King (BKW) sizzled today, rising 4% on the announcement that CEO Bernardo Hees is ending his reign. The fast food chain says Hees will take the top spot at H. J. Heinz after Berkshire Hathaway and 3G Capital take the ketchup-maker private. Chief Financial Officer Daniel Schwartz has been named to replace Hees on July 1st. Separately, Burger King says quarterly earnings will be 17-cents a share, slightly above estimates. The company did warn however

    Read More »from Dow Hits New High (Again!), Burger King Sizzles, Computer Makers Fizzle

Pagination

(1,000 Stories)

RATES

 
Recent Quotes
Symbol Price Change % Chg 
Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
You need to enable your browser cookies to view your most recent quotes.
 
Sign-in to view quotes in your portfolios.